Day One Biopharmaceuticals
South San Francisco, US · Founded 2018 · 234 employees on LinkedIn · 5 known investors
Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
Founders & leadership
JB
Jeremy BenderNamed on SEC filing
Board
MG
DD
JP
JJ
John JoseyBoard director
DB
Daniel BeckerBoard director
NH
Natalie HollesBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$130M disclosed across 1 of 2 rounds · 2021–2024
▶$130MraisedFeb 2021 · 24 investors · PharmaceuticalsRule 506(b)
▶$130MraisedFeb 2021 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy BenderExecutive Officer, Director
- Michael GladstoneDirector
- Derek DiRoccoDirector
- Julie Papanek GrantDirector
- John JoseyDirector
- Natalie HollesDirector
- Daniel BeckerDirector
- Offering amount
- $130M
- Amount sold
- $130M
- First sale
- Feb 2021
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Day One Biopharmaceuticals do?
- Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
- Who are Day One Biopharmaceuticals's investors?
- Day One Biopharmaceuticals's investors include Access Biotechnology, Atlas Venture, Canaan Partners, RA Capital, The Column Group.
- How much funding has Day One Biopharmaceuticals raised?
- Day One Biopharmaceuticals has disclosed $130M raised across 1 of its 2 known rounds.
- Where is Day One Biopharmaceuticals headquartered?
- Day One Biopharmaceuticals is headquartered in South San Francisco, US.